| Robert J Richardson, MD | |
|
700 Doctors Ct, Leesburg, FL 34748-7314 | |
| (352) 787-9838 | |
| (352) 787-8705 |
| Full Name | Robert J Richardson |
|---|---|
| Gender | Male |
| Speciality | Cardiac Surgery |
| Experience | 40 Years |
| Location | 700 Doctors Ct, Leesburg, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558399733 | NPI | - | NPPES |
| 253935700 | Medicaid | FL | |
| 42992 | Other | FL | BCBS FL |
| 42992A | Other | FL | BCBS FL |
| 42992B | Other | FL | BCBS FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208G00000X | Thoracic Surgery (cardiothoracic Vascular Surgery) | ME75610 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Uf Health Leesburg Hospital | Leesburg, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Florida Clinical Practice Association | 0345146254 | 1636 |
News Archive
According to a new federal government report, heart disease is the biggest killer in Australia, causing nearly 50,000 deaths a year.
Contraindicated antiplatelet use is rare but persists in patients undergoing percutaneous coronary intervention, show US study data.
Amira Pharmaceuticals, Inc. announced today that it will present preclinical and clinical data from its DP2 receptor antagonist program on December 17, 2010, at Pacifichem 2010 in Honolulu, Hawaii. The data from Amira's clinical-stage DP2 program will be delivered by Brian Stearns, Ph.D., in a presentation titled "Discovery and optimization of a novel series of DP2 antagonists with efficacy in mouse models of COPD and asthma."
Pseudobulbar affect (PBA) is a neurologic condition of involuntary, sudden and frequent episodes of laughing or crying and is quite common in patients with underlying neurologic diseases or injuries, especially those with multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS).
According to scientists a simple hand-held torch-like device can swiftly kill dangerous bacteria, offering a potential boon for emergency workers battling infection risks in wars or disaster zones. The device was created by an international team of researchers from China's Huazhong University of Science and Technology, Australia's CSIRO Materials Science and Engineering, the University of Sydney and the City University of Hong Kong.
› Verified 9 days ago
| Entity Name | Florida Clinical Practice Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063463768 PECOS PAC ID: 0345146254 Enrollment ID: O20031211000099 |
News Archive
According to a new federal government report, heart disease is the biggest killer in Australia, causing nearly 50,000 deaths a year.
Contraindicated antiplatelet use is rare but persists in patients undergoing percutaneous coronary intervention, show US study data.
Amira Pharmaceuticals, Inc. announced today that it will present preclinical and clinical data from its DP2 receptor antagonist program on December 17, 2010, at Pacifichem 2010 in Honolulu, Hawaii. The data from Amira's clinical-stage DP2 program will be delivered by Brian Stearns, Ph.D., in a presentation titled "Discovery and optimization of a novel series of DP2 antagonists with efficacy in mouse models of COPD and asthma."
Pseudobulbar affect (PBA) is a neurologic condition of involuntary, sudden and frequent episodes of laughing or crying and is quite common in patients with underlying neurologic diseases or injuries, especially those with multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS).
According to scientists a simple hand-held torch-like device can swiftly kill dangerous bacteria, offering a potential boon for emergency workers battling infection risks in wars or disaster zones. The device was created by an international team of researchers from China's Huazhong University of Science and Technology, Australia's CSIRO Materials Science and Engineering, the University of Sydney and the City University of Hong Kong.
› Verified 9 days ago
| Entity Name | Leesburg Cardiovascular Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952346017 PECOS PAC ID: 8729981238 Enrollment ID: O20040131000094 |
News Archive
According to a new federal government report, heart disease is the biggest killer in Australia, causing nearly 50,000 deaths a year.
Contraindicated antiplatelet use is rare but persists in patients undergoing percutaneous coronary intervention, show US study data.
Amira Pharmaceuticals, Inc. announced today that it will present preclinical and clinical data from its DP2 receptor antagonist program on December 17, 2010, at Pacifichem 2010 in Honolulu, Hawaii. The data from Amira's clinical-stage DP2 program will be delivered by Brian Stearns, Ph.D., in a presentation titled "Discovery and optimization of a novel series of DP2 antagonists with efficacy in mouse models of COPD and asthma."
Pseudobulbar affect (PBA) is a neurologic condition of involuntary, sudden and frequent episodes of laughing or crying and is quite common in patients with underlying neurologic diseases or injuries, especially those with multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS).
According to scientists a simple hand-held torch-like device can swiftly kill dangerous bacteria, offering a potential boon for emergency workers battling infection risks in wars or disaster zones. The device was created by an international team of researchers from China's Huazhong University of Science and Technology, Australia's CSIRO Materials Science and Engineering, the University of Sydney and the City University of Hong Kong.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert J Richardson, MD 700 Doctors Ct, Leesburg, FL 34748-7314 Ph: (352) 787-9838 | Robert J Richardson, MD 700 Doctors Ct, Leesburg, FL 34748-7314 Ph: (352) 787-9838 |
News Archive
According to a new federal government report, heart disease is the biggest killer in Australia, causing nearly 50,000 deaths a year.
Contraindicated antiplatelet use is rare but persists in patients undergoing percutaneous coronary intervention, show US study data.
Amira Pharmaceuticals, Inc. announced today that it will present preclinical and clinical data from its DP2 receptor antagonist program on December 17, 2010, at Pacifichem 2010 in Honolulu, Hawaii. The data from Amira's clinical-stage DP2 program will be delivered by Brian Stearns, Ph.D., in a presentation titled "Discovery and optimization of a novel series of DP2 antagonists with efficacy in mouse models of COPD and asthma."
Pseudobulbar affect (PBA) is a neurologic condition of involuntary, sudden and frequent episodes of laughing or crying and is quite common in patients with underlying neurologic diseases or injuries, especially those with multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS).
According to scientists a simple hand-held torch-like device can swiftly kill dangerous bacteria, offering a potential boon for emergency workers battling infection risks in wars or disaster zones. The device was created by an international team of researchers from China's Huazhong University of Science and Technology, Australia's CSIRO Materials Science and Engineering, the University of Sydney and the City University of Hong Kong.
› Verified 9 days ago
Ralph Duane Cook, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 801 E Dixie Ave, Leesburg, FL 34748 Phone: 352-742-1171 Fax: 352-742-7241 | |
Karen S Thompson, DO Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 700 Doctors Ct, Leesburg, FL 34748 Phone: 352-787-9838 Fax: 352-787-8705 |